| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.085 | 0.3 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |